Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1971 2
1972 1
1973 1
1976 2
1978 1
1979 1
1980 6
1981 4
1985 1
1988 2
1989 1
1990 3
1992 1
1994 3
1995 2
1996 2
1997 3
1998 3
1999 1
2000 2
2001 2
2002 3
2003 1
2004 5
2005 5
2006 5
2007 3
2008 6
2009 7
2010 6
2011 5
2012 7
2013 5
2014 10
2015 9
2016 7
2017 14
2018 17
2019 13
2020 24
2021 26
2022 20
2023 15
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C, Mannelli C, Riva L, Gainotti S, Gussoni G. Petrini C, et al. Among authors: riva l. Front Public Health. 2022 Dec 15;10:1081150. doi: 10.3389/fpubh.2022.1081150. eCollection 2022. Front Public Health. 2022. PMID: 36590004 Free PMC article. Review.
The Impact of Formula Choice for the Management of Pediatric Cow's Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study.
Nocerino R, Bedogni G, Carucci L, Cosenza L, Cozzolino T, Paparo L, Palazzo S, Riva L, Verduci E, Berni Canani R. Nocerino R, et al. Among authors: riva l. J Pediatr. 2021 May;232:183-191.e3. doi: 10.1016/j.jpeds.2021.01.059. Epub 2021 Jan 29. J Pediatr. 2021. PMID: 33524387 Free article. Clinical Trial.
[Heart-brain interactions].
Riva L, Urbinati S, Di Pasquale G. Riva L, et al. G Ital Cardiol (Rome). 2019 May;20(5):265-278. doi: 10.1714/3151.31319. G Ital Cardiol (Rome). 2019. PMID: 31066369 Italian.
Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA.
Yoh SM, Mamede JI, Lau D, Ahn N, Sánchez-Aparicio MT, Temple J, Tuckwell A, Fuchs NV, Cianci GC, Riva L, Curry H, Yin X, Gambut S, Simons LM, Hultquist JF, König R, Xiong Y, García-Sastre A, Böcking T, Hope TJ, Chanda SK. Yoh SM, et al. Among authors: riva l. Mol Cell. 2022 Aug 4;82(15):2871-2884.e6. doi: 10.1016/j.molcel.2022.06.010. Epub 2022 Jul 8. Mol Cell. 2022. PMID: 35809572 Free PMC article.
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
Yuan S, Yin X, Meng X, Chan JF, Ye ZW, Riva L, Pache L, Chan CC, Lai PM, Chan CC, Poon VK, Lee AC, Matsunaga N, Pu Y, Yuen CK, Cao J, Liang R, Tang K, Sheng L, Du Y, Xu W, Lau CY, Sit KY, Au WK, Wang R, Zhang YY, Tang YD, Clausen TM, Pihl J, Oh J, Sze KH, Zhang AJ, Chu H, Kok KH, Wang D, Cai XH, Esko JD, Hung IF, Li RA, Chen H, Sun H, Jin DY, Sun R, Chanda SK, Yuen KY. Yuan S, et al. Among authors: riva l. Nature. 2021 May;593(7859):418-423. doi: 10.1038/s41586-021-03431-4. Epub 2021 Mar 16. Nature. 2021. PMID: 33727703
[Hemodynamic effects of positive end-expiratory pressure].
Marini M, Caretta G, Vagnarelli F, Lucà F, Biscottini E, Lavorgna A, Procaccini V, Riva L, Vianello G, Aspromonte N, Mortara A, De Maria R, Capasso P, Valente S, Gulizia MM. Marini M, et al. Among authors: riva l. G Ital Cardiol (Rome). 2017 Jun;18(6):505-512. doi: 10.1714/2700.27611. G Ital Cardiol (Rome). 2017. PMID: 28631764 Review. Italian.
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.
Pal LR, Cheng K, Nair NU, Martin-Sancho L, Sinha S, Pu Y, Riva L, Yin X, Schischlik F, Lee JS, Chanda SK, Ruppin E. Pal LR, et al. Among authors: riva l. iScience. 2022 May 20;25(5):104311. doi: 10.1016/j.isci.2022.104311. Epub 2022 Apr 27. iScience. 2022. PMID: 35502318 Free PMC article.
Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW, Chan JF, Cao J, Poon VK, Herbert KM, Cheng K, Nguyen TH, Rubanov A, Pu Y, Nguyen C, Choi A, Rathnasinghe R, Schotsaert M, Miorin L, Dejosez M, Zwaka TP, Sit KY, Martinez-Sobrido L, Liu WC, White KM, Chapman ME, Lendy EK, Glynne RJ, Albrecht R, Ruppin E, Mesecar AD, Johnson JR, Benner C, Sun R, Schultz PG, Su AI, García-Sastre A, Chatterjee AK, Yuen KY, Chanda SK. Riva L, et al. Nature. 2024 Jul;631(8019):E3. doi: 10.1038/s41586-024-07659-8. Nature. 2024. PMID: 38890463 No abstract available.
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead.
Dayan Elshan NGR, Wolff KC, Riva L, Woods AK, Grabovyi G, Wilson K, Pedroarena J, Ghorai S, Nazarian A, Weiss F, Liu Y, Mazumdar W, Song L, Okwor N, Malvin J, Bakowski MA, Beutler N, Kirkpatrick MG, Gebara-Lamb A, Huang E, Nguyen-Tran VTB, Chi V, Li S, Rogers TF, McNamara CW, Gupta AK, Rahimi A, Chen JJ, Joseph SB, Schultz PG, Chatterjee AK. Dayan Elshan NGR, et al. Among authors: riva l. J Med Chem. 2024 Feb 22;67(4):2369-2378. doi: 10.1021/acs.jmedchem.3c01938. Epub 2024 Feb 9. J Med Chem. 2024. PMID: 38335279 Free PMC article.
261 results